COMMUNIQUÉS West-GlobeNewswire

Abeona Therapeutics Announces Authorization to Commence Phase 1/2 Gene Therapy Clinical Study for Patients with MPS IIIB in Spain
12/09/2018
Clinical trial for ABO-101 (AAV-NAGLU) marks the 2nd MPS III program in Europe Company plans to initiate additional clinical sites in European countries including France, Germany and the United Kingdom NEW YORK and [...]
Cambrex Completes Acquisition of Halo Pharma
12/09/2018
EAST RUTHERFORD, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced it has [...]
The medical condition 72 percent of Americans don’t know about is stealing sleep and disrupting lives, survey shows
12/09/2018
Over one-third of Americans wake up more than once per night to urinate due to a condition called nocturia, which can cause daytime tiredness and irritability, impair work productivity, increase risk of falls and injury [...]
Daxor Corporation to Exhibit at the 22nd Annual Scientific Meeting of the Heart Failure Society of America
12/09/2018
NEW YORK, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today [...]
Fortress Biotech Announces Publication of Preclinical Data on AAV-ATP7A Gene Therapy Combined with CUTX-101 (Copper Histidinate) for Menkes Disease in Molecular Therapy: Methods & Clinical Development
12/09/2018
NEW YORK, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Stealth Mark and Sunshine Minting, Inc. Form Strategic Alliance
12/09/2018
Introducing the Next Generation of Stealth Mark, Formula C2-4:18 HOFFMAN ESTATES, IL , Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Wellness Center USA, Inc.’s (OTCQB: WCUI) wholly-owned subsidiary, StealthCo, [...]
eUnity Smartviewer Helps DocPanel Create Disruptive Radiology Marketplace Experience
12/09/2018
WATERLOO, Ontario, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Client Outlook, a leading provider of FDA Class II enterprise diagnostic and clinical image viewing solutions, announced today their partnership with DocPanel [...]
NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier
12/09/2018
FT. MYERS, Fla., Sept. 12, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has been awarded a group purchasing agreement [...]
Pediapharm annonce des acquisitions transformatrices et un placement de 60 millions de dollars de reçus de souscription
12/09/2018
NON DESTINÉ À LA DISTRIBUTION AUX AGENCES DE PRESSE AMÉRICAINES NI À LA DIFFUSION AUX ÉTATS-UNIS LE NON-RESPECT DE CETTE RESTRICTION PEUT CONSTITUER UNE VIOLATION DE LA LÉGISLATION AMÉRICAINE SUR LES VALEURS MOBILIÈRES [...]
Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Efforts to Battle Opioid Epidemic
12/09/2018
MIAMI, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in [...]
Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT® FDA Clinical Trial
12/09/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes [...]
TrakCel to develop and supply Medeor Therapeutics with cellular supply chain management and orchestration system
12/09/2018
CARDIFF, United Kingdom, Sept. 12, 2018 (GLOBE NEWSWIRE) -- TrakCel, the cell and gene therapy supply chain tracking and orchestration system software developer, today announces it has been engaged to build a custom- [...]
XBiotech Announces Addition of World Leading Cardiologist Dr. Peter Libby to its Scientific Advisory Board
12/09/2018
AUSTIN, Texas, Sept. 12, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) is pleased to announce the appointment of Peter Libby, MD to its Scientific Advisory Board (SAB). Dr. Libby will work with XBiotech to help [...]
Immunomedics and Samsung BioLogics Announce Strategic Manufacturing Partnership
12/09/2018
Partnership Involves Commercial-scale Production of hRS7, the Antibody Used in Immunomedics’ Lead Antibody-Drug Conjugate, Sacituzumab Govitecan MORRIS PLAINS, N.J. and INCHEON, South Korea, Sept. 12, 2018 (GLOBE [...]
Athenex and its Collaborative Partner, Hanmi Pharmaceutical, Announce Strategic Realignment of their Joint Projects
12/09/2018
BUFFALO, N.Y., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Emblem signs supply agreement with Aphria to purchase up to 175,000 kg equivalents of cannabis products over five years
12/09/2018
TORONTO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis [...]
Actor Jeremy Miller Appears on Local ABC News Supporting BioCorRx Recovery Program
12/09/2018
ANAHEIM, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today [...]
MRI Interventions to Present at Sidoti & Co. 2018 Fall Conference on Sept 27
12/09/2018
LOS ANGELES, Sept. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC), announced today that Chief Executive Officer Joe Burnett will present at the Sidoti & Co. 2018 Fall Conference on Thursday, [...]
Apellis Pharmaceuticals Announces First Patient Dosed in Its Phase 3 Clinical Program for APL-2 in Patients With Geographic Atrophy
12/09/2018
CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Pages